Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

Journal of Neuro-Oncology

Volumn 72, Issue 2, 2005, Pages 125-131

  Boiardi, Amerigo ^a   Bartolomei, Mirco ^b   Silvani, Antonio ^a   Eoli, Marica ^a   Salmaggi, Andrea ^a   Lamperti, Elena ^a   Milanesi, Ida ^a   Botturi, Andrea ^a   Rocca, Paola ^b   Bodei, Lisa ^a   Broggi, Giovanni ^a   Paganelli, Giovanni ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Locoregional chemotherapy; Locoregional radioimmunotherapy; Mitoxantrone; Recurrent glioblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; DEXAMETHASONE; MITOXANTRONE; YTTRIUM 90;

ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN EDEMA; BRAIN HEMORRHAGE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG DELIVERY SYSTEM; FOCAL EPILEPSY; GLIOBLASTOMA; HEADACHE; HUMAN; HYDROCEPHALUS; INJECTION SITE REACTION; LEUKOPENIA; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; POSTOPERATIVE PERIOD; RADIOIMMUNOTHERAPY; SINGLE DRUG DOSE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE MARROW DISEASES; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; INFUSIONS, INTRALESIONAL; MIDDLE AGED; MITOXANTRONE; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; RADIOIMMUNOTHERAPY; YTTRIUM RADIOISOTOPES;

EID: 20444411528     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-004-1497-5     Document Type: Article

References (37)

1. MD Walker SB Green DP Byar Ejr Alexander U Batzdorf WH Brooks WE Hunt CS McCarty MS Mahavley Jr J Mealey G Owens J Ransohoff JT Robertson WR Shapiro KR Smith Jr CB Wilson TA Strike 1980 Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1323-1327 1:STN:280:Bi6D2M3htF0%3D 7001230
2. HA Fine KBG Dear YS Loeffler PML Black GP Canellos 1993 Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 2585-2597 1:STN:280:ByyB3c7kvVM%3D 8453582
3. EORTC Brain Tumor Group 1978 Effect of CCNU on survival rate, objective remission and duration of free interval in patients with malignant brain glioma. Final evaluation. Eur J Cancer 14 851-856
4. PL Kornblith M Walker 1998 Chemotherapy for malignant gliomas J Neurosurg 68 1-17
5. T Tomita 1991 Interstitial chemotherapy for brain tumors: Review J Neuro-oncol 10 57-74 10.1007/BF00151247 1:STN:280:By6B3MjntFI%3D
6. A Boiardi A Salmaggi A Pozzi G Broggi A Silvani 1996 Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data J Neuro-oncol 27 157-162 10.1007/BF00177479 1:STN:280:BymB3svns10%3D
7. A Boiardi A Silvani AL Pozzi L Fariselli G Broggi G Salmaggi 1999 Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: Improved survival in sequential studies J Neuro-oncol 41 151-157 10.1023/A:1006119505170 1:STN:280:DyaK1M3jvV2nsw%3D%3D
8. H Brem S Piantadossi P Burger M Walker RW Selker NA Vick K Black M Sisti S Brem G Mohr P Muller R Morawetz SC Schold 1995 controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas.The Polymer-brain Tumor Treatment Group. Lancet 345 1008-1012 1:STN:280:ByqB2c%2FisVU%3D 7723496
9. S Valtonen U Timonen P Toivanen H Kalimo L Kivipelto O Heiskanen G Usgaard T Kuurne 1997 Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study Neurosurg 41 44-49 1:STN:280:ByiA287ktVQ%3D 9218294
10. EP Sipos B Tyler S Piantadosi PC Burger H Brem 1997 Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors Cancer Chemother Pharmacol 39 383-389 10.1007/ s002800050588 1:CAS:528:DyaK2sXis1ajsb8%3D 9054951
11. LK Fung MG Ewend A Sills EP Sipos R Thompson M Watts OM Colvin H Brem WM Salzman 1998 Pharmacokinetics of interstitial delivery of carmustine 4-hydroperoxycyclophosphamide and paclitaxel from a biodegradable polymer implant in the monkey brain Cancer Res 58 672-684 1:CAS:528:DyaK1cXht1antbY%3D 9485020
12. P Riva A Arista V Tison C Sturiale G Franceschi A Spinelli N Riva M Casi G Moscatelli M Frattarelli 1994 Intralesional radioimmunotherapy of malignant gliomas.An effective treatment in recurrent tumors. Cancer 73 1076-1082 1:STN:280:ByuC3sfosVc%3D 8306250
13. G Paganelli M Bartolomei M Ferrari M Cremonesi G Broggi G Maira C Sturiale C Grana G Prisco M Gatti P Caliceti M Chinol 2001 Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results Cancer Biother Radiopharm 16 227-235 10.1089/10849780152389410 1:CAS:528:DC%2BD3MXlsV2qtLw%3D 11471487
14. G Akabani CJ Reist I Cokgor AH Friedman HS Friedman RE Coleman XG Zhao DD Bigner MR Zalutsky 1999 Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors J Nucl Med 40 631-638 1:CAS:528:DyaK1MXisFOitrk%3D 10210222
15. P Perego A Boiardi N Carenini M De Cesare E Dolfini R Giardino I Magnani A Silvani C Soranzo 1994 Characterisation of an established human malignat glioblastoma cell line and its response to conventional grugs J Cancer Res Clin Oncol 120 585-592 10.1007/BF01212812 1:CAS:528:DyaK2MXis1yjurc%3D 7929529
16. JP Jordan CM Hand RS Markowitz P Black 1992 Test for chemotherapeutic sensitivity of cerebral gliomas: Use of colorimetric MTT assay J Neuro-oncol 14 19-35 10.1007/BF00170942 1:STN:280:ByyC3cfgtlw%3D
17. M Senkal JC Tonn R Schonmayr W Schachenmayr U Eickhoff M Kemen E Kollig 1987 Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors J Neuro-oncol 32 203-208 10.1023/A:1005792410604
18. DR MacDonald TL Cascino S Clifford 1990 Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277-1280 1:STN:280:By%2BB1MzotFM%3D 2358840
19. MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden PP Carbone 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649-655 1:STN:280:BiyC2cbntlU%3D 7165009
20. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
21. M Huncharek J Muscat 1998 Treatment of recurrent high grade astrocytoma; results of a systematic review of 1415 patients Anticancer Res 18 1303-1312 1:STN:280:DyaK1c3nvVSnsw%3D%3D 9615807
22. A Boiardi M Eoli A Salmaggi B Zappacosta L Fariselli I Milanesi G Broggi A Silvani 2001 Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumors J Neuro-oncol 54 39-47 10.1023/ A:1012510513780 1:STN:280:DC%2BD38%2Fjtl2qsA%3D%3D
23. C Nieder AL Grosu M Molls 2000 A comparison of treatment results for recurrent malignant gliomas Cancer Treat Rev 26 397-409 10.1053/ ctrv.2000.0191 1:STN:280:DC%2BD3M7gvVKitw%3D%3D 11139371
24. M Brada K Hoang-Xuan R Rampling PY Dietrich LY Dirix D Macdonald JJ Heimans BA Zonnenberg JM Bravo-Marques R Henriksson R Stupp N Yue J Bruner M Dugan S Rao S Zaknoen 2001 Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 149-150 10.1023/A:1008382516636 11300316
25. AA Brandes M Ermani U Basso P Amista F Berti R Scienza A Rotilio G Pinna M Gardiman S Monfardini 2001 Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study Ann Oncol 12 149-150 10.1023/A:1008382516636 11300316
26. J Dinnes C Cave S Huang R Milne 2002 A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma Br J Cancer 12 499-500
27. L Sipos D Vitanovics D Afra 2002 Treatment of recidive malignant gliomas with temozolomide Orv Hetil 143 1201-1204 12073541
28. DM Lieberman DW Laske PF Morrison KS Bankiewicz EH Oldfield 1995 Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion J Neurosurg 82 1021-1029 1:CAS:528:DyaK2MXmsVGmsL8%3D 7539062
29. RJ White FE Durr 1985 Development of mitoxantrone Invest New Drugs 3 85-93 10.1007/BF00174154 1:CAS:528:DyaL2MXltlChs74%3D 2410393
30. Green RM, Stewart DJ, Hugenholtz H, Richard MT, Thibault M, Montpetit V: Human central nervous system and plasma pharmacology of mitoxantrone. J Neuro-oncol: 75-83,1988
31. DJ Stewart RM Green NZ Mikhael V Montpetit M Thibault JA Maroun 1986 Human autopsy tissue concentration of mitoxantrone Cancer Treat Rep 70 1255-1261 1:STN:280:BiiD38fgt10%3D 3768871
32. G Broggi P Ferroli A Franzini A Silvani A Salmaggi M Eoli A Boiardi 2003 Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats J Neurosurg 98 935-936 12691429
33. P Riva A Arista G Franceschi M Frattarelli C Sturiale N Riva M Casi R Rossitti 1995 Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: Comparison of the results obtained in recurrent and newly diagnosed tumors Cancer Res 55 5952-5956
34. P Riva G Franceschi N Riva M Casi M Santimaria M Adamo 2000 Role of nuclear medicine in the treatment of malignant gliomas: The locoregional radioimmunotherapy approach Eur J Nucl Med 27 601-609 10.1007/ s002590050549 1:STN:280:DC%2BD3cvjs1antw%3D%3D 10853818
35. H Proske DO Schachtschabel N Paul R Pfab 1992 Electron microscopic studies on the effects of irradiation and mitoxantrone alone or in combination on cells of Harding Passey melanoma in monolayer culture Strahler Onkol 168 361-368 1:STN:280:By2A38%2FkslU%3D
36. C Linassier C Barin G Calais S Letortorec JL Bremond M Delain A Petit MT Georget G Cartron N Raban L Benboubker R Leloup C Binet JP Lamagnere P Colombat 2000 Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy Ann Oncol 11 1289-1294 10.1023/ A:1008375016038 1:STN:280:DC%2BD3MzgsVKltA%3D%3D 11106118
37. C Grana M Chinol C Robertson C Mazzetta M Bartolomei C De Cicco M Fiorenza M Gatti P Caliceti G Paganelli 2002 Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study Br J Cancer 21 207-212 10.1038/sj.bjc.6600047